Title of article :
Morbilliform rashes due to erythromycin in a patient with herpes zoster infection
Author/Authors :
Dwari, Binayak Chandra Manipal College of Medical Sciences - Manipal Teaching Hospital - Departments of Dermatology and Venereal Disease, Nepal , Bajracharya, Surichhya Manipal College of Medical Sciences - Manipal Teaching Hospital - Department of Dermatology and Venereal Disease, Nepal , Mishra, Pranaya Manipal College of Medical Sciences - Hospital and Clinical Pharmacy, Manipal Teaching Hospital - Departments of Pharmacology, Nepal , Palaian, Subish Manipal College of Medical Sciences - Hospital and Clinical Pharmacy, Manipal Teaching Hospital - Departments of Pharmacology, Nepal , Prabhu, Smitha Kasturba Medical College - Department of Dermatology, India , Prabhu, Mukhyaprana Kasturba Medical College - Department of Medicine, India
Abstract :
Erythromycin is a macrolide antibiotic active against many gram-positive infections and few gram-negative bacteria, as well as mycoplasmas, spirochetes, chlamydiae and rickettsiae. Dermatological reactions appear to be rare with erythromycin and mainly include maculopapular rashes, pruritus, urticaria, and angioedema, Reports of morbiliform rashes due to erythromycin are rare. We report a case of morbiliform reaction due to erythromycin in a patient suffering from herpes zoster with established causality, severity and preventability assessments. Upon development of the adverse drug reaction, we stopped the drug and managed the patient with systemic corticosteroids
Keywords :
Erythromycin , morbilliform rashes , causality , severity , preventability
Journal title :
Journal of Pakistan Association of Dermatologists
Journal title :
Journal of Pakistan Association of Dermatologists
